Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gretel Trullenque

Family Medicine Miami, FL Doctor of Osteopathy

NPI 1720076144 CMS profile 32746

1021 Ives Dairy Rd Ste 214, Suite 301, Miami, FL 33179

Open in the dashboard

General payments

$8,391

202 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,305,326 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gretel Trullenque of Miami, FL is reported in the CMS Open Payments database as having received $8,391 across 202 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,305,326 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,221 5
2024 General $1,983 17
2023 General $2,005 9
2022 General $192 9
2021 General $259 14
2020 General $1,356 79
2019 General $1,374 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gretel Trullenque
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Gretel Trullenque were reported at $1,221. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Gretel Trullenque Family Medicine median Middle half National median
2019 $1,374 $150 $41–$543 $163
2020 $1,356 $120 $32–$415 $114
2021 $259 $137 $35–$551 $132
2022 $192 $137 $37–$512 $149
2023 $2,005 $149 $42–$545 $160
2024 $1,983 $156 $44–$560 $164
2025 $1,221 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $2,173 17 payments
  2. E.R. Squibb & Sons, L.L.C. $1,784 16 payments
  3. Novartis Pharmaceuticals Corporation $1,321 11 payments
  4. AstraZeneca Pharmaceuticals LP $434 21 payments
  5. Janssen Pharmaceuticals, Inc $371 19 payments
  6. Novo Nordisk Inc $338 18 payments
  7. Galderma Laboratories, L.P. $290 2 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $288 17 payments
  9. Sanofi-Aventis U.S. LLC $242 12 payments
  10. Lilly USA, LLC $239 16 payments
  11. Other $911 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,728 191 payments
  2. Travel and Lodging $3,663 11 payments
Products named General payments · program years 2019–2025
  1. XARELTO $371 19 payments
  2. Ozempic $314 17 payments
  3. FARXIGA $296 15 payments
  4. JARDIANCE Diabetes $288 17 payments
  5. SOLIQUA 100/33 $221 11 payments
  6. INVOKANA $204 11 payments
  7. RYBELSUS $204 11 payments
  8. TRULICITY $194 13 payments
  9. JARDIANCE Diabetes $178 12 payments
  10. SYNJARDY $158 9 payments
  11. Other $2,260 125 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

202 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record